Connective tissue disease can be hereditary, but the answer depends on which type you’re asking about. Some connective tissue disorders are caused by a single gene mutation passed directly from parent to child, making them clearly inherited conditions. Others, particularly autoimmune connective tissue diseases like lupus and rheumatoid arthritis, are not inherited in that straightforward way. Instead, they involve a genetic predisposition that increases risk but doesn’t guarantee the disease will develop.
Two Categories With Different Genetics
Connective tissue diseases fall into two broad groups, and they behave very differently when it comes to heredity. The first group includes structural disorders caused by mutations in genes that build or maintain connective tissue. Marfan syndrome, for example, results from a mutation in the gene that produces the protein fibrillin-1. Ehlers-Danlos syndrome involves mutations affecting collagen or related proteins. These are caused by single-gene changes and follow predictable inheritance patterns. If a parent carries the mutation, each child has a defined probability of inheriting it.
The second group includes autoimmune connective tissue diseases, where the immune system mistakenly attacks the body’s own connective tissues. Lupus, rheumatoid arthritis, scleroderma, and mixed connective tissue disease fall into this category. These are not caused by one gene. They result from a combination of many genetic variants, each contributing a small amount of risk, layered on top of environmental triggers like cigarette smoke, air pollution, ultraviolet light exposure, and infections.
How Marfan and Ehlers-Danlos Are Inherited
Marfan syndrome follows an autosomal dominant pattern, meaning you only need one copy of the mutated gene (from one parent) to develop the condition. A parent with Marfan syndrome has a 50% chance of passing the mutation to each child. The same autosomal dominant pattern applies to several forms of Ehlers-Danlos syndrome, including classical EDS (caused by mutations in collagen type V genes), vascular EDS (collagen type III), and hypermobile EDS, though the specific gene for hypermobile EDS has not yet been identified.
Other EDS subtypes follow an autosomal recessive pattern, meaning a child must inherit a mutated copy from both parents to be affected. These include dermatosparaxis EDS, cardiac-valvular EDS, kyphoscoliotic EDS, and several rarer forms. In recessive inheritance, parents are typically carriers who show no symptoms themselves. Myopathic EDS is unusual in that it can follow either a dominant or recessive pattern depending on the specific mutation involved.
Because these disorders are tied to identifiable gene mutations, genetic testing can confirm a diagnosis and clarify the exact inheritance risk for family members. A clinical geneticist can guide testing, interpret results, and explain what the findings mean for relatives.
Genetic Risk in Autoimmune Connective Tissue Disease
Autoimmune connective tissue diseases don’t follow neat inheritance patterns. Instead, certain gene variants make the immune system more likely to malfunction, and dozens or even hundreds of these variants may contribute small amounts of risk. The most well-studied are genes in the HLA system, which helps the immune system distinguish the body’s own tissues from foreign invaders. Specific HLA variants are strongly linked to rheumatoid arthritis. In European populations, particular versions of the HLA-DRB1 gene that encode what researchers call the “shared epitope” are major risk factors. Different populations carry different risk variants: East Asian patients more commonly carry one version, while certain Native American groups carry another.
Beyond HLA genes, variants in genes involved in immune signaling also contribute. A variant in the PTPN22 gene, which affects how immune cells are regulated, is associated with rheumatoid arthritis and several other autoimmune diseases in people of European descent. Another relevant gene, PADI4, codes for an enzyme involved in a chemical modification of proteins that the immune system can mistakenly target.
Lupus has a similar genetic landscape. Twin studies provide the clearest window into how much genetics matters: when one identical twin has lupus, the other twin develops it about 24% of the time. For non-identical twins, that drops to just 2%. The gap between 24% and 100% tells you that genes are important but far from the whole story. If lupus were purely genetic, identical twins would always share the diagnosis.
What the Risk Looks Like for Families
If you have lupus and you’re wondering about your children, the numbers are reassuring. According to Johns Hopkins Medicine, only about 2% of children whose mothers have lupus will develop it themselves. Relatives of people with lupus do have a greater chance than the general population, but that elevated risk is still relatively small in absolute terms.
Mixed connective tissue disease (MCTD) shows some familial clustering. Documented cases include a mother and daughter who both developed MCTD, and families where one member had MCTD while another developed lupus. These cases suggest shared genetic susceptibility across related autoimmune conditions, not just one specific disease. A family history of any autoimmune connective tissue disease may slightly increase your risk of developing a related condition, even if it’s not the same one.
Why Genes Alone Don’t Tell the Full Story
Even when you carry genetic risk variants for autoimmune connective tissue disease, whether those genes become active depends partly on epigenetic changes. These are chemical modifications to your DNA that don’t alter the genetic code itself but control whether particular genes are turned on or off. DNA methylation, one of the most studied epigenetic mechanisms, plays a key role in immune cell development. Environmental exposures like smoking, UV light, and chemical pollutants can alter these epigenetic patterns, effectively flipping switches that activate immune-related genes in people who were already genetically susceptible.
This is why autoimmune connective tissue diseases often appear to “run in families” without following a clear inheritance pattern. Family members share both genes and, often, similar environmental exposures. Separating those two influences is difficult, which is why the hereditary component of these diseases is described as a predisposition rather than a certainty.
When Genetic Testing Helps
For structural connective tissue disorders like Marfan syndrome and most forms of Ehlers-Danlos syndrome, genetic testing can confirm a diagnosis and identify the exact mutation. This is valuable not just for the person being tested but for family planning and for screening relatives who may carry the same mutation without obvious symptoms. Testing typically involves a referral from your primary care doctor to a clinical geneticist, who can select the appropriate gene panel based on your symptoms and family history.
For autoimmune connective tissue diseases, genetic testing is less useful in a clinical setting. There’s no single gene to test for, and carrying risk variants doesn’t mean you’ll develop the disease. Family history remains the most practical tool for estimating risk. If multiple close relatives have autoimmune conditions, particularly lupus, rheumatoid arthritis, or scleroderma, that pattern is worth mentioning to your doctor, as it may influence how aggressively early symptoms are investigated.